| Eleni P Bourtsos, MD | |
|
120 N Oak St, Hinsdale Hospital/pathology Department, Hinsdale, IL 60521-3829 | |
| (630) 856-8750 | |
| (630) 856-7895 |
| Full Name | Eleni P Bourtsos |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 30 Years |
| Location | 120 N Oak St, Hinsdale, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467453951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist La Grange Memorial Hospital | La grange, IL | Hospital |
| Adventist Hinsdale Hospital | Hinsdale, IL | Hospital |
| Adventist Glenoaks | Glendale heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Du Page Pathology Associates Sc | 4284606310 | 8 |
News Archive
A novel software tool, developed at The Children's Hospital of Philadelphia, streamlines the detection of disease-causing genetic changes through more sensitive detection methods and by automatically correcting for variations that reduce the accuracy of results in conventional software.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Face masks are thought to slow the spread of viruses, including the novel coronavirus that causes COVID-19, but little is known about how well they work.
Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.
› Verified 9 days ago
| Entity Name | Du Page Pathology Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003815457 PECOS PAC ID: 4284606310 Enrollment ID: O20040810000521 |
News Archive
A novel software tool, developed at The Children's Hospital of Philadelphia, streamlines the detection of disease-causing genetic changes through more sensitive detection methods and by automatically correcting for variations that reduce the accuracy of results in conventional software.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Face masks are thought to slow the spread of viruses, including the novel coronavirus that causes COVID-19, but little is known about how well they work.
Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eleni P Bourtsos, MD 520 E 22nd St, Lombard, IL 60148-6110 Ph: (630) 874-2542 | Eleni P Bourtsos, MD 120 N Oak St, Hinsdale Hospital/pathology Department, Hinsdale, IL 60521-3829 Ph: (630) 856-8750 |
News Archive
A novel software tool, developed at The Children's Hospital of Philadelphia, streamlines the detection of disease-causing genetic changes through more sensitive detection methods and by automatically correcting for variations that reduce the accuracy of results in conventional software.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.
Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.
Face masks are thought to slow the spread of viruses, including the novel coronavirus that causes COVID-19, but little is known about how well they work.
Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.
› Verified 9 days ago
Rita Noronha, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 120 W North St, Hinsdale Hospital / Pathology Department, Hinsdale, IL 60521 Phone: 630-856-8750 Fax: 630-856-7895 | |
Roland E. Lonser, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 120 N Oak St, Hinsdale Hospital / Pathology Dep, Hinsdale, IL 60521 Phone: 630-856-7850 Fax: 630-856-7895 | |
Agnieszka U. Piotrowski, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 120 N Oak St, Hinsale Hospital / Pathology Depar, Hinsdale, IL 60521 Phone: 630-856-8750 Fax: 630-856-7895 | |
Dr. Erlo Roth, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 120 E Ogden Ave Ste 14, Hinsdale, IL 60521 Phone: 630-986-9622 Fax: 630-986-0720 | |
Marisa Saint Martin, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 120 N Oak St, Hinsdale, IL 60521 Phone: 630-856-7850 Fax: 630-856-7895 | |
Lena Kubba, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 120 N Oak St, Hinsdale Hospital / Pathology Department, Hinsdale, IL 60521 Phone: 630-856-9000 | |
Joann Y Hutto, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 120 N Oak St, Hinsdale Hospital, Pathology Department, Hinsdale, IL 60521 Phone: 630-856-7850 |